Skip to content
Home/Companies/Healthcare/Symetis
SY

Symetis

Healthcare·Switzerland·Exited 2017·Held 16yr

Symetis is a healthcare company, headquartered in Switzerland.

Entry
2001
Hold
16yr
Exit
2017
Est. EV
–

Who owns Symetis?

Symetis was owned by Truffle Capital through Truffle Capital Legacy (pre-2019) (2010 vintage) from 2001 to 2017, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-11

Truffle Capital
Investor
Truffle Capital
Truffle Capital Legacy (pre-2019) · 2010 · VC

Key facts

HQSwitzerland
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017

More from Truffle Capital Legacy (pre-2019)

Other portfolio companies in the same fund.

NEW GENERATION NATURAL GAS
Active
EnergyFrance· 2017
PHARNEXT
Exited 2024
SoftwareFrance· 2017
RETENCY
Exited 2024
SoftwareFrance· 2017
Skinosive
Active
HealthcareFrance· 2017
ACERDE
Exited 2021
SoftwareFrance· 2016
to
Seacure
Active
SoftwareFrance· 2016

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings